T-5

Product NDC
58264-0250
Requested package NDC
58264-0250-1
11-digit product format
582640250
Labeler code
58264
Product ID
58264-0250_2b539c7f-71e9-1665-e063-6294a90ab35a
Type
HUMAN OTC DRUG
Nonproprietary name
CERATOSTIGMA WILLMOTTIANUM WHOLE
Dosage form
SOLUTION
Route
SUBLINGUAL
Labeler
DNA Labs, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
1990-01-01
Substance
CERATOSTIGMA WILLMOTTIANUM WHOLE
Active strength
30 [hp_X]/mL
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 5 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2022-04-09 23:13 UTC · source 2022-04-0886f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01bd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-278dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17e2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-109bebd1f3094a…5416666fcb17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
T-5
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CERATOSTIGMA WILLMOTTIANUM WHOLE30 [hp_X]/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
U8O5LNX3QTInternal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4a20f2eb-1b54-4a27-be47-b02f85f66d4cAvailable on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
58264-0250-12022-04-29C16284748780-19d75b9d0-24ac-f424-e053-dadaa90a57ceT-5
58264-0250-12020-01-31C16284748780-19d75b9d0-24ac-f424-e053-dadaa90a57ceT-5

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58264-0250-1T-529.57 mL in 1 BOTTLE, GLASSSOLUTION29.574

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58264-0250T-5 (CERATOSTIGMA WILLMOTTIANUM WHOLE) SOLUTION [DNA LABS, INC.]4Current NDC, Legacy NDC, 1 package rows20250112_4a20f2eb-1b54-4a27-be47-b02f85f66d4c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
T-5CERATOSTIGMA WILLMOTTIANUM WHOLEDNA Labs, Inc.4a20f2eb-1b54-4a27-be47-b02f85f66d4c2025-01-09WarningsExact identifier
ndc (package): 58264-0250-1
ndc (product): 58264-0250
ndc11 (package): 58264025001

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
58264-0250-15826402500129.57 mL in 1 BOTTLE, GLASS (58264-0250-1) 29.57 ml1990-01-010000-00-00NoNoCurrent